pentobarbital will reduce the level or impact of buprenorphine, extended-acting injection by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Closely. Patients who transfer to buprenorphine extended-performing injection from transmucosal buprenorphine coadministered with CYP3A4 inducers need to be monitored to be sure b